The full 35k+ dataset is free for everyone. Sign up for favourites, or upgrade to Pro for premium features.

Feature	Free	Sign Up	Pro	Pro+
35,000+ assets	✓	✓	✓	✓
Education library	✗	✓	✓	✓
Filter by Country & Sector	✗	✓	✓	✓
Ad-Free Mobile App Experience	✗	✗	✓	✓
News Article Access	✗	✗	✓	✓
Favourites	3	15	50/mo	Unlimited
Flippener Tool	3	10	30/mo	Unlimited
Comparator Tool	3	5	15/mo	Unlimited
Price	Free	Sign Up	$3.99/mo	$9.99/mo

Create a free account

Already have an account? Log in

Register for your free API key (top 100 assets included). Subscribe for the full 35k+ dataset, fundamentals, and historical data.

Feature	Free	Starter	Growth	Scale
Top 100 assets	✓	✓	✓	✓
Full 35k+ asset list	✗	✓	✓	✓
Fundamentals	✗	✓	✓	✓
Historical data	✗	✓	✓	✓
Calls / month	1,000	10k	100k	1M
Price	Free	$19.99/mo	$49.99/mo	$99.99/mo

View API documentation →

The global leaderboard of wealth: $1.2 Quadrillion of Assets ranked by Market Cap

News

All Commodities Companies Crypto Currencies Featured Flippenings Macro Premium

In-depth research + analysis available with Pro ($3.99/mo) or Pro Plus ($9.99/mo). Everything else on this page is free.

Article

Nova Minerals Corp (NVA) Discusses Estelle Gold and Critical Minerals Project Updates and U.S. Antimony Supply Chain Award Transcript

Premium Oct 19, 2026

Article

Strategy buys another $22 million of Bitcoin, increases planned share buybacks

Premium Oct 19, 2026

Article

Ethereum’s faster proofs face Vitalik’s next test: a hard cost limit

Premium Oct 19, 2026

Article

XRP holders can now earn fees from Kraken’s DeFi customers, but there is a catch

Premium Oct 19, 2026

Companies

Here’s Why BP p.l.c. (BP) is One of UK’s High Dividend Stock to Buy

finance.yahoo.com · Jun 24, 2026 · 1 min read

Companies

BKLN: Tight Credit Premium Combined With High Expense Decreases The Allocation Appeal

seekingalpha.com · Jun 24, 2026 · 1 min read

Companies

The 2 Signals That Will Determine IBIT’s Next 12 Months

finance.yahoo.com · Jun 24, 2026 · 1 min read

Companies

Vertex Pharmaceuticals: Povetacicept May Redefine Growth Narrative (Rating Upgrade)

seekingalpha.com · Jun 24, 2026 · 1 min read

Companies

Verastem, Inc. (VSTM) Discusses Preliminary TARGET-D 101 Data for VS-7375 in KRAS G12D Mutated Cancers - Slideshow

seekingalpha.com · Jun 24, 2026 · 1 min read

Companies

Financial Freedom: Moving From Stock Scorecards To Perpetual Cash Flow

In a market conditioned by a 17-year bull run, many investors are overlooking the risks of extreme equity valuations. Shifting from a traditional stock-centric investment strategy to a cash flow-oriented approach can enhance financial security. This article explores the implications of historical market behaviors, the risks of high equity allocations, and the benefits of creating a self-sustaining cash flow engine. ## BODY: ### The State of the Market: A History of Overconfidence The past 17